Bull
$2.26
Precio del escenario
$0.201
-0.004 (-1.85%)Al cierre
ESSA Pharma Inc. is a Canada-based pharmaceutical company that was previously focused on developing therapies for the treatment of patients with prostate cancer. The Company is undergoing a comprehensive review process to review its strategic options to maximize shareholder value.
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

ESSA Announces Completion of Arrangement with XenoTherapeutics

ESSA Shareholders Give Green Light to XenoTherapeutics Acquisition

ESSA Pharma reduces shareholder distribution in updated Xeno agreement

ESSA Pharma Inc. Amends Agreement with XenoTherapeutics

Essa Pharma Inc. to Adjourn Special Meeting to September 29, 2025
ESSA Pharma Inc. is a Canada-based pharmaceutical company that was previously focused on developing therapies for the treatment of patients with prostate cancer. The Company is undergoing a comprehensive review process to review its strategic options to maximize shareholder value. It operates in the Financials sector (PHARMACEUTICAL PREPARATIONS industry).
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.